Does ARIPIPRAZOLE Cause Product use in unapproved indication? 4,792 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 4,792 reports of Product use in unapproved indication have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 7.2% of all adverse event reports for ARIPIPRAZOLE.
4,792
Reports of Product use in unapproved indication with ARIPIPRAZOLE
7.2%
of all ARIPIPRAZOLE reports
138
Deaths
2,035
Hospitalizations
How Dangerous Is Product use in unapproved indication From ARIPIPRAZOLE?
Of the 4,792 reports, 138 (2.9%) resulted in death, 2,035 (42.5%) required hospitalization, and 250 (5.2%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 4,792 reports have been filed with the FAERS database.
What Other Side Effects Does ARIPIPRAZOLE Cause?
Drug ineffective (5,566)
Off label use (5,473)
Weight increased (4,636)
Anxiety (3,076)
Suicide attempt (2,796)
Suicidal ideation (2,618)
Condition aggravated (2,157)
Insomnia (2,147)
Akathisia (2,107)
Somnolence (2,055)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which ARIPIPRAZOLE Alternatives Have Lower Product use in unapproved indication Risk?
ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL
ARIPIPRAZOLE vs ARIXTRA
ARIPIPRAZOLE vs ARMODAFINIL
ARIPIPRAZOLE vs AROMASIN
ARIPIPRAZOLE vs ARSENIC TRIOXIDE